What is the initial treatment for hospital inpatients with rhabdomyolysis, specifically for Physical Medicine and Rehabilitation (PM&R) treatment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Initial Treatment of Rhabdomyolysis in Hospital Inpatients for PM&R

Aggressive intravenous fluid resuscitation with isotonic saline is the cornerstone of initial treatment for hospital inpatients with rhabdomyolysis, targeting a urine output of >300 mL/hour to prevent acute kidney injury. 1, 2, 3

Diagnosis Confirmation and Initial Assessment

  • Monitor serum creatine kinase (CK) levels every 6-12 hours in the acute phase, with rhabdomyolysis typically diagnosed when CK is at least 10 times the upper limit of normal 1
  • Check for myoglobinuria (tea/cola-colored urine) that tests positive for blood on dipstick but negative for RBCs on microscopy 1
  • Assess for the classic triad of myalgia, muscle weakness, and pigmenturia, though this is present in less than 10% of cases 1
  • Perform baseline kidney function tests, electrolyte panel, and urinalysis 1

Immediate Treatment Protocol

Fluid Resuscitation

  • Begin aggressive hydration with isotonic saline (0.9% NaCl) as the initial fluid of choice 1, 4
  • Target urine output >300 mL/hour to prevent acute kidney injury 1, 3
  • Avoid potassium-containing fluids such as Lactated Ringer's 1
  • Continue IV fluids until CK levels decrease to <1,000 U/L 3

Electrolyte Management

  • Monitor and correct hyperkalemia urgently if present 1
  • Address hypocalcemia if symptomatic 1
  • Check serum electrolytes, urea nitrogen, and creatinine during treatment 5

Additional Interventions

  • Discontinue any causative agents (e.g., statins) 1
  • Avoid all nephrotoxic medications, including NSAIDs, ACE inhibitors/ARBs, and certain antibiotics 1
  • Monitor for and treat compartment syndrome if present, with urgent surgical consultation for fasciotomy if confirmed 1

Evidence-Based Considerations

  • Current evidence does not strongly support routine use of bicarbonate-containing fluids or mannitol 2, 6, 4
  • A systematic review by the Eastern Association for the Surgery of Trauma conditionally recommends against treatment with bicarbonate or mannitol in patients with rhabdomyolysis 2
  • Early and aggressive fluid resuscitation is the main intervention with consistent evidence for preventing and treating AKI 6

Monitoring and Follow-up

  • Monitor CK levels until they decrease to <1,000 U/L 3
  • Assess kidney function regularly to detect acute kidney injury early 1
  • Consider nephrology consultation for all cases with acute kidney injury 1
  • Consider renal replacement therapy for severe hyperkalemia, acidosis, volume overload, or uremic symptoms 1

Complications to Monitor

  • Acute kidney injury (occurs in up to 57% of untreated cases) 1
  • Electrolyte abnormalities, particularly hyperkalemia 1
  • Compartment syndrome (monitor for pain, tension, paresthesia, and paresis in affected limbs) 1
  • Cardiac arrhythmias due to electrolyte disturbances 1

PM&R-Specific Considerations

  • Begin early mobilization once the patient is medically stable
  • Implement gradual return to activity based on CK levels and clinical symptoms
  • Provide education on proper hydration and exercise techniques to prevent recurrence
  • Develop a rehabilitation plan that addresses any residual muscle weakness or functional limitations

By following this evidence-based approach focusing on aggressive fluid resuscitation and careful monitoring, PM&R specialists can effectively manage rhabdomyolysis in hospital inpatients while preventing serious complications like acute kidney injury.

References

Guideline

Rhabdomyolysis in Patients on Statin Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Rhabdomyolysis.

Chest, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.